Clinical Trial Update: Acetyl-L-carnitine in Combination With a Cisplatin-containing Chemotherapy as First Line Treatment of Advanced or Metastatic Non Small Cell Lung Cancer [Phase 3]

View source ↗

Summary

A Phase 3 trial of Acetyl-L-carnitine in combination with a cisplatin-containing chemotherapy as first-line treatment for advanced or metastatic non-small cell …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Acetyl-L-carnitine (N-acetyl-L-carnitine)
• CISPLATIN (cisplatin)

Snippet

Sponsor: Mario Negri Institute for Pharmacological Research | Conditions: Non Small Cell Lung Cancer | Phase 3 | Status: TERMINATED